Mengyun Yue
Key Laboratory Of Rare Neurological Diseases Of Jiangxi Provincial Health Commission
Nanchang, 330006, China
Nanchang, 330006, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Engineered Clostridium butyricum-pMTL007-GLP-1 Delays Neurodegeneration in Prnp-SNCA*A53T Transgenic Mice Model by Suppressing Astrocyte Senescence.
Journal: Probiotics and antimicrobial proteins
Published: June 20, 2025
The engineered probiotic strain Lactococcus lactis MG1363-pMG36e-GLP-1 regulates microglial polarization and gut dysbiosis in a transgenic mouse model of Parkinson's disease.
Journal: Neural regeneration research
Published: June 26, 2024
Bifidobacterium longum SX-1326 ameliorates gastrointestinal toxicity after irinotecan chemotherapy via modulating the P53 signaling pathway and brain-gut axis.
Journal: BMC microbiology
Published: October 23, 2023
The intestinal microbiota exerts a sex-specific influence on neuroinflammation in a Parkinson's disease mouse model.
Journal: Neurochemistry international
Published: July 18, 2023
LncRNA TSIX knockdown restores spinal cord injury repair through miR-30a/SOCS3 axis.
Journal: Biotechnology & genetic engineering reviews
Published: April 04, 2023
Neurotrophic Role of the Next-Generation Probiotic Strain L. lactis MG1363-pMG36e-GLP-1 on Parkinson's Disease via Inhibiting Ferroptosis.
Journal: Nutrients
Published: October 14, 2022
Evaluation of the Anti-Aging Effects of a Probiotic Combination Isolated From Centenarians in a SAMP8 Mouse Model.
Journal: Frontiers in immunology
Published: October 11, 2021
Neuroprotective Effect of Ceftriaxone on MPTP-Induced Parkinson's Disease Mouse Model by Regulating Inflammation and Intestinal Microbiota.
Journal: Oxidative medicine and cellular longevity
Published: August 08, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026